Vanguard Group Discloses Position in Mural Oncology

The Vanguard Group, Inc. has released a Form 8.3 in connection with Mural Oncology plc as per Irish Takeover Panel regulations. This disclosure relates to Vanguard's interests and short positions in Mural Oncology, citing a total of 772,515 $0.01 ordinary shares, which represent 4.47% of the relevant securities.

The filing date of the position is 28 July 2025. Vanguard disclosed that there hadn't been dealings in cash-settled or stock-settled derivatives related to Mural Oncology. Furthermore, no indemnity agreements or other arrangements that could influence dealings were noted.

This announcement confirms Vanguard’s ongoing reporting obligation under Rule 8.3 of the Irish Takeover Panel. It's a routine step for entities with significant investment interests in publicly traded companies.